1.	Evaluating the Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 to 75 Sponsor: NIMH Protocol IDs: R01 MH071580, DATR A3-NSS, NCT00352885
2.	Intervention Study of Depression in Breast Cancer Patients Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 20 to 65 Sponsor: Other Protocol IDs: 2009BAI77B06-3, NCT01256008
3.	Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment Phase: Phase III Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: TADDOR, CSET 1388, NCT00935675
4.	Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000585065, P30CA015083, MC0738, 07-006133, NCI-2011-00406, MAYO-MC0738, NCT00667121